Erythropoietin attenuated vascular dysfunction and inflammation by inhibiting NADPH oxidase-derived superoxide production in nitric oxide synthase-inhibited hypertensive rat aorta-Reference-Cited by-同舟云学术

Erythropoietin attenuated vascular dysfunction and inflammation by inhibiting NADPH oxidase-derived superoxide production in nitric oxide synthase-inhibited hypertensive rat aorta

Published:2012-09 Issue:1-3 Volume:691 Page:190-197
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Toba Hiroe,Kojima Yushi,Wang Jiahong,Noda Kazuki,Tian Wei,Kobara Miyuki,Nakata Tetsuo

Publisher

Elsevier BV

Subject

Pharmacology

Reference48 articles.

1. Mechanism of activation and function of protein kinase B;Alessi;Curr. Opin. Genet. Dev.,1998

2. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure;Bahlmann;Circulation,2004

3. The impact of early normalization of haematocrit by erythropoietin on renal damage in the remnant kidney model;Bellizzi;Nephrol. Dial. Transplant.,1998

4. Adhesion molecules and atherosclerosis;Blankenberg;Atherosclerosis,2003

5. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase;Burger;Cardiovasc. Res.,2006

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on intranasal treatment for Parkinson's disease;Neuroprotection;2024-04-21

2. A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan;Frontiers in Cardiovascular Medicine;2023-01-18

3. The Effects of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Erythropoietin, and Their Interactions in Angiogenesis: Implications in Retinopathy of Prematurity;Cells;2022-06-17

4. Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms;Cardiovascular Drugs and Therapy;2022-02-12

5. Short-term Tolerance of Nasally-administered NeuroEPO in Patients with Parkinson Disease;MEDICC Review;2021